|
Trial of Early Noninvasive Ventilation for Amyotrophic Lateral Sclerosis (ALS) |
Michigan |
Completed |
Amyotrophic Lateral Sclerosis |
|
Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS) Trial |
Multiple U.S. Locations |
Completed |
Amyotrophic Lateral Sclerosis |
|
Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis |
Maryland* |
Completed |
Multiple Sclerosis, Relapsing-Remitting |
|
Safety, Tolerability, and Effectiveness of CGP77116 in Patients With Multiple Sclerosis (MS) |
Maryland |
Completed |
Multiple Sclerosis |
|
Aspirin Or Warfarin To Prevent Stroke |
Georgia |
Terminated |
Stroke, Cerebral Infarction, Atherosclerosis, Constriction, Pathologic |
|
Quantitative Imaging and Proton Spectroscopy in Multiple Sclerosis |
New York |
Terminated |
Multiple Sclerosis |
|
Study to Investigate the Safety and Efficacy of Lithium in Volunteers With Amyotrophic Lateral Sclerosis (ALS) |
Multiple U.S. Locations |
Terminated |
Amyotrophic Lateral Sclerosis |
|
Oral Guanabenz for Multiple Sclerosis |
Maryland* |
Terminated |
Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis |
|
Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe) |
Maryland* |
Terminated |
Multiple Sclerosis |
|
Idebenone for Primary Progressive Multiple Sclerosis |
Maryland* |
Enrolling by Invitation |
Multiple Sclerosis, Primary Progressive Multiple Sclerosis |
